Quick Overview: Madappa Kundranda, MD, PhD, a medical oncologist at Banner MD Anderson Cancer Center, discusses the frontline therapeutic ... Triparna Sen, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the role of Sahil Doshi, MD, of Memorial Sloan Kettering Cancer Center, highlights his retrospective analysis presented at the 2024 ...
Evaluating Systemic Therapies Available For - Detailed Overview & Context
Madappa Kundranda, MD, PhD, a medical oncologist at Banner MD Anderson Cancer Center, discusses the frontline therapeutic ... Triparna Sen, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the role of Sahil Doshi, MD, of Memorial Sloan Kettering Cancer Center, highlights his retrospective analysis presented at the 2024 ... Expert panelists Daniel George, MD; Nicholas J. Vogelzang, MD, FASCO, FACP; Bradley McGregor, MD; and Robert Alter, MD, ... In this video, Dr. Diane Gehart reviews the foundational Dr Mark Kris continues a discussion about considerations related to the many faces of progression on
Nicholas McAndrew, MD, MSCE, UCLA Health, Santa Monica, CA, discusses the findings of a subgroup analysis Website: Twitter: Facebook: LinkedIn: ... Mark Yarchoan, MD, Johns Hopkins University, Baltimore, MD, provides an overview of emerging immunotherapy biomarkers for ... This video is part of a larger CE/CME Certified program entitled: The Evolving Role of Checkpoint Inhibitors as Frontline Dr Breelyn Wilky discusses past, present, and future Ghassan K. Abou-Alfa, MD, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, discusses a ...
Thank you to AbbVie for their support on this FAQ Video Module. In this FAQ video module, Brooke Hodnick, PA-C, breaks down ... James Song, MD, FAAD, the director of clinical research at Frontier Dermatology in Washington, discusses the severity of ... In this episode, Dr. Eli sits down with Dr. Priest to discuss the theory-driven Richard S. Finn, MD, comments on the use of liver-directed
